Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2341718rdf:typepubmed:Citationlld:pubmed
pubmed-article:2341718lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0017526lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0376152lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:2341718lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:2341718pubmed:issue11lld:pubmed
pubmed-article:2341718pubmed:dateCreated1990-6-28lld:pubmed
pubmed-article:2341718pubmed:abstractTextIL-6 enhances the differentiation of pluripotent hematopoietic stem cells but predominantly affects the differentiation of hematopoietic cells in the granulocyte-macrophage lineage. We have previously shown that multinucleated cells (MNC) with many features of the osteoclast phenotype form in long term human marrow cultures. Addition of rhIL-6 (10 to 100 pg/ml) to these cultures significantly increased MNC formation, with greater than 80% of the MNC expressing an Ag that cross-reacts with the mAb 23c6. This antibody preferentially binds to osteoclasts. rhIL-6 did not enhance MNC formation in marrow cultures treated with 1,25 dihydroxyvitamin D3, a potent stimulator of MNC formation, but significantly increased the percentage of MNC that cross-reacted with the 23c6 mAb. Addition of antihuman IL-1 to cultures treated with rhIL-6 totally inhibited the increase in MNC formation stimulated by rhIL-6. In contrast, anti-IL-1 did not affect MNC formation stimulated by 1,25 dihydroxyvitamin D3. Further, conditioned media from marrow cultures exposed to rhIL-6 contained elevated levels of IL-1 beta (500 pg/ml compared to 23 pg/ml in control cultures 15 h after IL-6 addition). These results suggest that the capacity of rhIL-6 to stimulate formation of MNC which cross-react with 23c6 is mediated by induction of release of IL-1 beta.lld:pubmed
pubmed-article:2341718pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:languageenglld:pubmed
pubmed-article:2341718pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2341718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2341718pubmed:statusMEDLINElld:pubmed
pubmed-article:2341718pubmed:monthJunlld:pubmed
pubmed-article:2341718pubmed:issn0022-1767lld:pubmed
pubmed-article:2341718pubmed:authorpubmed-author:KuriharaNNlld:pubmed
pubmed-article:2341718pubmed:authorpubmed-author:BertoliniDDlld:pubmed
pubmed-article:2341718pubmed:authorpubmed-author:SudaTTlld:pubmed
pubmed-article:2341718pubmed:authorpubmed-author:AkiyamaYYlld:pubmed
pubmed-article:2341718pubmed:authorpubmed-author:RoodmanG DGDlld:pubmed
pubmed-article:2341718pubmed:issnTypePrintlld:pubmed
pubmed-article:2341718pubmed:day1lld:pubmed
pubmed-article:2341718pubmed:volume144lld:pubmed
pubmed-article:2341718pubmed:ownerNLMlld:pubmed
pubmed-article:2341718pubmed:authorsCompleteYlld:pubmed
pubmed-article:2341718pubmed:pagination4226-30lld:pubmed
pubmed-article:2341718pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:meshHeadingpubmed-meshheading:2341718-...lld:pubmed
pubmed-article:2341718pubmed:year1990lld:pubmed
pubmed-article:2341718pubmed:articleTitleIL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release.lld:pubmed
pubmed-article:2341718pubmed:affiliationResearch Service, Audie Murphy VA Hospital, San Antonio, TX 78284.lld:pubmed
pubmed-article:2341718pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2341718pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2341718pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2341718pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2341718lld:pubmed